CLINICAL TRIALS

Clinical Trials

Phase 2 study for hypertension and CKD with albuminuria

Phase 3 study for ASCVD and CKD in BMI >27

Phase 3 study for EFFICACY OF Baxdrostat for hypertension and CKD with albuminuria

Phase 3 study for efficacy of Zibotentan/Dapagloflozin in CKD with proteinuria

Phase 3 study for subjects with ASCVD or at risk of first CV event: Lp (a) study

Phase 3 study for efficacy of Zibotentan/Dapagloflozin in CKD with proteinuria